Sign inJoin waitlistJoin the waitlist

Omar S. Aljitawi

Professor - Department of Medicine, Hematology/Oncology · URochester Medicine

Credentials: · · · · ·

History

URochester Medicine
Present

City of Hope National Medical Center
2007–2008
University of Kansas Medical Center
2004–2007
East Tennessee State University College of Medicine
2002–2004
East Tennessee State University College of Medicine
2001–2002
Bashir Hospital
1999–2000
University of Jordan
1999

Research

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Blood · 2015 · 549 citations
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double…
Blood · 2011 · 458 citations
Stem cell homing: From physiology to therapeutics
Review · Stem Cells · 2020 · Last of 3 authors · 180 citations

Joseph McGuirk
33 papers
Siddhartha Ganguly
29 papers
Sunil Abhyankar
29 papers
Tara Lin
20 papers
Anurag Singh
8 papers
Jane Liesveld
6 papers
LS
Leyla Shune
6 papers
RH
Richard Hopkins
6 papers
Brea Lipe
5 papers
Jason Mendler
5 papers
Michael Becker
5 papers
Dennis Allin
4 papers

Grants

Hyperbaric Oxygen to Improve Blood Count Recovery in Auto-HCT for Myeloma
National Cancer Institute · R37
Contact PI · $1.7M · University of Rochester
2018–2025

Clinical trials

Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT
Principal investigator · Completed · Early phase 1
University of Rochester
2022–2025
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
Principal investigator · Recruiting · Early phase 1
Omar Aljitawi
2020–2028
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
Principal investigator · Active not recruiting · Phase 2
University of Rochester
2019–2027
Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma
Principal investigator · Completed · Phase 2
Omar Aljitawi
2018–2023